Clinical trial
A Randomized Study Comparing the Effects of PF708 and Forteo in Patients With Osteoporosis
NCT03002428 is registered in ClinicalTrials.gov with Pfenex, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Study Comparing the Effects of PF708 and Forteo in Patients With Osteoporosis
- Lead sponsor
- Pfenex, Inc
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- May 31, 2018
- Enrollment
- 181 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.